June 24, 2013
To whom it may concern:
Company Name : TOHO HOLDINGS CO., LTD.
Representative : Norio Hamada /President and Representative Director(Securities Code: 8129 / First Section of Tokyo Stock Exchange)
Contact: Katsuya Kato
Corporate Officer and General Manager ofCorporate Communications Officeand Corporate Planning Office(TEL: 03-5259-9520)

Notice Regarding the Commencement of Negotiation Concerning the Inclusion of Two Wholly Owned Subsidiaries
into the Business Integration among Five Wholly Owned Sub-subsidiaries
TOHO HOLDINGS CO., LTD. is pleased to announce that it has resolved to proceed with consultations towards a businessmerger on November 1, 2013 (planned) among seven companies consisting of two newly invited Company’s wholly-ownedsubsidiaries, Japan Pharmacy Co., Ltd. (“Japan Pharmacy” hereinafter) and Yotsuba Co., Ltd. (“Yotsuba” hereinafter) and theexisting five wholly-owned sub-subsidiaries, Tomonity Inc. (“Tomonity” hereinafter), Pharma Square Co., Ltd. (“PharmaSquare” hereinafter), Mirai Corporation (“Maria” hereinafter), Nest Co., Ltd. (“Nest” hereinafter) and Jus-Pharma Co., Ltd.
(“Jus Pharma” hereinafter) announced on May 27 this year. An outline is as follows.
It should be noted that, because the business consolidation only involves the Company’s wholly-owned consolidated
subsidiary and its consolidated sub-subsidiaries, the disclosures that would otherwise be required are provided herein withcertain omissions.

１． Purpose of consolidation
The Group adopts a business management and control system under which our wholly-owned subsidiary PharmaCluster
Co., Ltd. plays a central role in dispensing pharmacy businesses. The Company considers that its five wholly-owned
sub-subsidiaries, Tomonity, Pharma Square, Mirai, Nest and Jus-Pharma will be able to further reinforce the pharmacy
functions and maximize the Group companies’ corporate value by actively utilizing the Group’s management resources,and has been proceeding with consultations towards business merger. However, the Company has now decided tocommence negotiations towards a business merger among seven companies further including two wholly-owned
subsidiaries, Japan Pharmacy and Yotsuba.
In addition, the Company will continue to discuss the business reorganization within the Group to strengthen themanagement base of the dispensing pharmacy business.
２． Objectives of consolidation(1) Schedule of consolidation
The end of July 2013
November 1, 2013

The agreement of consolidation (planned)
Date of consolidation (planned)(2) Method of consolidation / Details of share allotment
The method of consolidation and details of the share allotment will be specified in the near future after consultations by
the Group companies in charge of the operation and management of the dispensing pharmacies, including the Companyand PharmaCluster Co., Ltd.

1

３． Outlines of parties involved in the consolidation(1) Company name Tomonity Inc.
(2) Business contents Dispensing Pharmacy Business(3) Establishment
July 7, 1993
(4) Principal place
4-4-2, Honcho, Nihonbashi, Chuo-ku,
Tokyo(5) CorporateToshiyuki Tsukuda
representative(6) Capital
50 million yen(7) Number of shares 400,000
issued(8) Fiscal year end
March 31(9) Major
shareholders andequity holdings

PharmaCluster Co., Ltd. 100％

Pharma Square Co., Ltd.
Dispensing Pharmacy Business
July 1, 1989
4-4-2, Honcho, Nihonbashi, Chuo-ku,
TokyoKatsuhiro Yoshimoto
50 million yen
100,000
March 31
PharmaCluster Co., Ltd. 100％

(1)
(2)
(3)
(4)Company name Mirai Corporation
Nest Co., Ltd.
Business contents Dispensing Pharmacy Business
Dispensing Pharmacy Business
Establishment
March 31, 1981
April 30, 2010
Principal place
3-5-13, Heijima, Nishi-ku, Niigata city, 1-3-7, Kimachidori, Aoba-ku, Sendai
Niigatacity, Miyagi(5) Corporate
Takeshi Kurita
Masao Motohashi
representative(6) Capital
36 million yen
50 million yen(7) Number of shares 900
1,000
issued(8) Fiscal year end
March 31
March 31(9) Major
shareholders andequity holdings

PharmaCluster Co., Ltd. 100％

(1) Company name Jus-Pharma Co., Ltd.
(2) Business contents Dispensing Pharmacy Business(3) Establishment
November 11, 1989
(4) Principal place
3-4139-11, Ishikawa, Mito city, Ibaraki(5) Corporate
Sadao Kimura
representative(6) Capital
10 million yen(7) Number of shares 10,000
issued(8) Fiscal year end
March 31(9) Major
shareholders andequity holdings

PharmaCluster Co., Ltd. 100％2

PharmaCluster Co., Ltd. 100％

(1)
(2)
(3)
(4)

Company nameBusiness contents
Establishment
Principal place(5) Corporate
representative(6) Capital(7) Number of sharesissued(8) Fiscal year end(9) Major
shareholders andequity holdings

Japan Pharmacy Co., Ltd.
Dispensing Pharmacy Business
May 13, 1992
4-5-12 Hongoku-cho, Nihonbashi,Chuo-ku, Tokyo
Takahiro Kanno

Yotsuba Co., Ltd.
Dispensing Pharmacy Business
September 11, 1996
1-4-15 Hirakawa-cho Chiyoda-ku
Tokyo
Saburo Tanaka

50 million yen
1,000

44.8 million yen
896

March 31
Toho Holdings Co., Ltd. 100％

March 31
Toho Holdings Co., Ltd. 100％

４． Effects of consolidation
The trade name, location of the main office, the title and the name of the representatives, the amount ofcapital and the term for the settlement of accounts will be decided after consultations among the relatedparties, including the Company and PharmaCluster Co., Ltd.
５． Outlook
Since the planned consolidation is a part of the Group’s reorganization involving only the Company’s
wholly-owned sub-subsidiaries, the impact it will have on the Company’s consolidated financial results
for the fiscal year ending March 2014 is expected to be minimal.

3